- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06462157
Group Compassionate Mind Training for Adults Experiencing the Menopause Transition
The Feasibility and Effects of Group Compassionate Mind Training for Adults Experiencing the Menopause Transition: a Preliminary Investigation
Menopause transition occurs naturally for women aged 45-55. In addition to the hormone changes, there are often changes in other areas of life including low mood, anxiety, 'brain fog' and embarrassment. Some people may not be eligible for or want to receive hormone replacement therapy, therefore psychological treatments for menopause have been investigated. There is growing evidence for the use of Compassionate Mind Training (CMT). CMT aims to reduce feelings of self-criticism and shame which are commonly reported by adults experiencing the menopause, by helping individuals to take better care of themselves, known as self-compassion. Findings show menopausal individuals who are more self-critical may be more vulnerable to difficulties during menopause. Therefore, CMT could help manage this. CMT improves self-compassion and reduces depressive symptoms, with group formats found to be more effective than individual or self-help. A previous study of online self-help CMT for the menopause received positive feedback for the therapy and people improved in several areas including self-compassion. Clearly, there could be benefits to offering CMT as a treatment for menopause. Given that group CMT is effective in other populations and groups are more economical and practical for the NHS, this study is interested in looking at the impact of group CMT on menopause.
This study aims to find out how practical and suitable group CMT is for improving the wellbeing of adults experiencing the menopause, and what their views are on the therapy and taking part in the study. To measure the aims, we will look at the ease of recruiting people to the study, whether they are happy to be randomly allocated to receive the therapy or not, whether they stay in the study, the number of completed questionnaires and feedback from participants. It will also look at whether there have been any changes in different domains e.g. anxiety and self-compassion. This will be done through a variety of quantitative and qualitative outcomes.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
County
-
London, County, United Kingdom, WC1E 6BT
- University College London
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults (aged 40-60) who are biologically female
- Women who are experiencing symptoms of the menopause or peri-menopause; which is naturally occurring. This is identified through the STRAW criteria. Individuals have to answer Yes on at least one of the STRAW screening questions to ensure women are in the perimenopause or menopausal period.
- Substantial English verbal communication and comprehension skills
- Capacity to consent
- Confident in using video conferencing applications (MsTeams)
- Willingness to take part in a post-intervention interview about their experience.
- PHQ-9 score 5-19 (mild to moderate clinical cut offs)
- GAD-7 score 5-15 (mild to moderate clinical cut offs)
Exclusion Criteria:
- People under the age of 40
- People currently receiving any form of psychology intervention.
- Transgender females who are biologically male
- More than 5 years post menopause.
- PHQ-9 score greater or equal to 20 (severe clinical cut off)
- GAD-7 score greater or equal to 15 (severe clinical cut off)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Treatment as usual
|
|
|
Experimental: Online CMT groups
Online Compassionate Mind Training
|
Participants will attend 6 x 90-minute online CMT sessions.
CMT is delivered by combining taught information, exercises, and practices.
It is effective, so the aim is to explore its use with menopausal women.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Revised Women's Health Questionnaire
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures health-related quality of life by measuring perceptions of physical and emotional experiences of middle-aged women.
All subscales are scored from yes, definitely (1) to no, not at all (4) with subscales scored with a scoring algorithm transforming each score to a 0-100 scale.
|
To be completed within one week before and within one week after the intervention
|
|
36-Item Short Form Survey
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures quality of life.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
|
To be completed within one week before and within one week after the intervention
|
|
The Menopause Representations Questionnaire (MRQ)
Time Frame: To be completed within one week before and within one week after the intervention
|
Measure to assess beliefs about menopause.
It consists of 20 items, scored either no (0), uncertain (1) or yes (2).
Higher scores indicate more beliefs about the menopause.
|
To be completed within one week before and within one week after the intervention
|
|
Fears of Compassion Scale
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures fears of compassion.
It has 38 items, scored either dont agree at all (0) to completely agree (4) on a Likert scale.
There are three subscales, subscale items are summed, with higher scores indicating higher fears of compassion.
|
To be completed within one week before and within one week after the intervention
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures severity of depression.
Score from 0-27, higher scores represent higher severity of symptoms of depression.
|
To be completed within one week before and within one week after the intervention
|
|
General Anxiety Disorder-7 (GAD-7)
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures severity of anxiety.
Score from 0-21, higher scores represent higher severity of symptoms of anxiety.
|
To be completed within one week before and within one week after the intervention
|
|
The forms of Self Criticising/Attaching & Self-reassuring scale (FSCRS) SELF-REASSURING SCALE (FSCR
Time Frame: To be completed within one week before and within one week after the intervention
|
Measures self criticism and the ability to self-reassure.
It is a 22-item scale with the items making up three components; inadequate self, hatred self and self-reassure.
Responses are given on a 5-point likert scale (0 = not at all lime me, to 4 = extremely like me).
Higher scores indicate a greater sense of inadequacy (score 0-20), self-hate (score 0-16), and self-reassurance (score 0-20).
|
To be completed within one week before and within one week after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post intervention interviews
Time Frame: Within 5 weeks post intervention
|
Qualitative data on experiences from the group
|
Within 5 weeks post intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aimee Spector, UCL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 26701/001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Western Norway University of Applied SciencesCompleted
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
Aydin Adnan Menderes UniversityUludag UniversityCompletedMenopause | Menopause Related ConditionsTurkey (Türkiye)
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasCompletedMenopause Related ConditionsUnited States
Clinical Trials on Compassionate Mind Training
-
University of CoimbraFundação para a Ciência e a TecnologiaActive, not recruiting
-
Queen's University, BelfastRecruiting
-
University of CoimbraCompassionate Mind Foundation; Reed FoundationCompleted
-
i4HealthCompassionate Mind FoundationCompletedComparison of Internet-based CBT and CMTUnited States
-
i4HealthCompletedPostpartum DepressionUnited States
-
Institut de Myologie, FranceEnrolling by invitationMyotonic Dystrophy Type 1France
-
Kırıkkale UniversityNot yet recruiting
-
Radboud University Medical CenterTriodos FoundationCompletedRecurrent DepressionNetherlands
-
NHS LanarkshireUniversity of GlasgowCompletedIntellectual DisabilityUnited Kingdom
-
University of ManchesterGreater Manchester Mental Health NHS Foundation TrustNot yet recruitingBipolar Disorder I or IIUnited Kingdom